AppliedVR is unleashing the power of Immersive Therapeutics (ITx), a new category of medical devices that harness the unique properties of virtual reality (VR) to treat some of the most debilitating chronic conditions. AppliedVR’s easy-to-use and engaging non-pharmacological platform enables patients to access our validated therapies from the comfort of home. The Company’s flagship product, RelieVRx®, is the first VR-based FDA-authorized medical device to treat chronic lower back pain (CLBP), a condition that affects 72 million adults in the US alone. RelieVRx has achieved multiple industry firsts including a unique CMS code and coverage category, paving the pathway to broad accessibility. Learn more about AppliedVR, headquartered in Los Angeles, at appliedvr.io.
AppliedVR’s RelieVRx® program optimizes the proven benefits of cognitive behavioral therapy (CBT) through a sequential, immersive therapeutic program which activates the brain’s innate healing power. Rigorously validated to reduce pain and pain intensity in multiple clinical trials totaling over 1,200 patients, RelieVRx is the first prescription virtual reality medical device to receive Breakthrough Device Designation and De Novo authorization by the FDA for the treatment of chronic lower back pain. For more information, visit relievrx.com.
Elysium Health’s mission is to solve the biggest challenges in health with science, to help people live healthier for longer. Elysium works directly with top scientists, clinicians and health professionals around the world to translate advances in science and technology into innovative health products that work. Our product development pipeline begins with research and development, continues with preclinical studies, and culminates with human clinical trials to demonstrate the safety and efficacy of products. Throughout this process, Elysium’s focus is to develop compounds found in nature that allow people to support their health proactively.
Elysium is guided by a Scientific Advisory Board, which includes multiple winners of the Nobel Prize, as well as researchers and doctors who are experts in chemistry, physiology, neuroscience, complex chemical systems, biochemistry, and many other fields of study.
Basis, Elysium Health’s first product, is a proprietary formulation of two ingredients designed to support long-term health at the cellular level. Basis is clinically proven to increase NAD+ levels, which decline with age. NAD+ is required for energy creation, regulating circadian rhythms, maintaining healthy DNA, and hundreds of other biological functions.
Limbix is passionate about delivering mental health treatment to young people who need it the most, when they need it the most. Our team is uniquely suited to develop prescription digital therapeutics, as we understand the value of pairing clinical expertise with technological innovation. Our diverse team of clinicians, product designers, researchers, and engineers are all focused on one thing: improving the lives of teens through accessible mental health treatment.